Medical examination meaning

MH Site Maintenance Services Ltd and another company v Watson [2025] EWCA Civ 775 What are the practical implications of this case? Insurers, and the solicitors representing them, will recognise the recurring problem: multiple requests for details, evidence, or progress updates go unanswered or are simply ignored, with the result that the defendant remains in the dark about the case it must confront, even years after promptly admitting liability. A further, and troubling, hallmark of these matters is their tendency to inflate in value, having been ‘incubated’ under the Protocol while a stay persists for months, or even years, as the claimant continues to secure medical evidence to strengthen their position. It is expected that this ruling sends a firm message to claimants that the prevailing habit of delay, coupled with a presumed right to a stay that can be rolled over time and again without examination, will no longer be accepted. Claimants will be required to move matters forward and actively progress these claims...

In this issue: Public procurement Children's social care Governance Social housing Social care Local government finance Healthcare Education Planning Daily and weekly news alerts New and updated content Public procurement Preparing for the Procurement Act 2023—new practical guidance On 24 February 2025, the principal provisions of the Procurement Act 2023 (PA 2023) take effect. Any procurements starting on or after that date must follow PA 2023, while exercises launched under earlier public procurement legislation will continue to be run and managed under those provisions. For background reading, see Practice Notes: Public procurement reform and Introduction to the Procurement Act 2023—PA 2023. As the PA 2023 ‘go-live’ was deferred last year, government departments, public bodies and local authorities have been steadily preparing for the change, whilst still conducting their procurement activities under the existing rules. Under the transitional and saving provisions for PA 2023, both regimes will operate side by side, in...

In this issue: Competition in life sciences Disputes and regulatory enforcement Regulatory framework for medicinal products Medical devices Research and development Daily and weekly news alerts New and updated content Dates for your diary Trackers Useful information Competition in life sciences CAT publishes decisions on Allergan PLC v CMA cases The Competition Appeal Tribunal (CAT) has released two judgments on the Competition and Markets Authority’s (CMA) conclusion that Auden/Actavis UK paid AMCo/Advanz to keep its own 10 mg hydrocortisone tablets off the market. In the first, the tribunal upholds the decision on the facts and dismisses every ground of appeal. In the second, it allows the appeals because the CMA failed to put its case fully to a witness during a two‑day cross‑examination at trial, thereby overturning nearly £100m in fines for the drug companies, despite earlier confirmation of flagrant anti‑competitive conduct. The CMA has said that permitting these ‘due process’ appeals on...

This Practice Note outlines the matters an employer must weigh up when obtaining medical assessment reports for their staff and prospective recruits...

The Pre-Action Protocol for Low Value Personal Injury Claims in Road Traffic Accidents This Practice Note provides a hands-on summary of the key elements of Stage 2 and 3 of the Pre-Action Protocol for Low Value Personal Injury Claims in Road Traffic Accidents, together with an examination of leading case law and the practical consequences for those operating within the online portal. Note: The Pre-Action Protocol for Personal Injury Claims Below the Small Claims Limit in Road Traffic Accidents (the RTA Small Claims Protocol) applies to accidents occurring on or after 31 May 2021 where the sum claimed for injuries is not more than £5,000 and the total value of the claim is not more than £10,000. The small claims track limit for personal injury claims arising from a road traffic accident is £5,000 for damages for pain, suffering and loss of amenity (PSLA), subject to specified exceptions. For more on the RTA Small Claims Protocol, including when it does not apply, see Practice Note: The road traffic...

This Practice Note This Practice Note describes the procedure for defending nullity proceedings where the application was issued before 6 April 2022. It clarifies when an answer must be lodged, who is entitled to file it, and includes practical drafting tips. The rules on service and on applying for medical examinations are covered, as are the requirements for making requests for further information. It also sets out the stages for case management hearings and the conduct of final hearings. Key procedural steps are highlighted for practitioners. On 6 April 2022, the Divorce, Dissolution and Separation Act 2020 (DDSA 2020) came into force. Although DDSA 2020 did not change the substantive law on nullity, it led to consequential procedural updates under the amended Family Procedure Rules 2010 (FPR 2010), SI 2010/2955. These affect applications for nullity and nullity of marriage orders issued on or after 6 April 2022. The updates relate chiefly to revised terminology, refreshed forms, and amended provisions concerning service. For the procedure governing proceedings begun on...

[ insert date ] [ insert employee’s name and address ] Private and confidential Dear [ insert name ] Consent to medical report from your doctor Further to [ your meeting with [ insert name ] on [ insert date ] ], we wish to secure your permission to request a written report from your [ GP OR consultant ] regarding your health. This may require a medical examination...

[ insert date ] [ insert employee’s name and address ] Private and confidential Dear [ insert name ] Consent to medical report by [ Company doctor ] Further to your meeting with [ insert name ] on [ insert date ], [ we OR We ] are seeking your consent to obtain a written medical report about you from [ the Company doctor ]. In order to prepare this report, [ the Company doctor ] could be required to carry out a medical examination of you, or be allowed access to your medical records [ covering the period from [ insert date ] to [ insert date ] ] from your GP or consultant and, where necessary, to discuss those records with your GP or consultant...

1 Introduction 1.1 Our people are the Company’s greatest asset, and safeguarding their health and safety is of the highest priority. The Company is committed to maintaining healthy, safe and productive working conditions for all staff at all times. Alcohol or drug misuse can undermine employees’ health and wellbeing and put the ongoing success of our business at risk. We recognise that these substances may affect an individual’s ability to work correctly and safely; accordingly, we seek to provide and maintain a workplace free from the inappropriate use of substances, where employees can carry out their duties efficiently and without danger. We also accept that, in certain cases, an alcohol or drug issue may constitute an illness. 1.2 Employees must also exercise reasonable care for their own safety and for others who might reasonably be affected by their actions. 1.3 There are often clear warning signs that could indicate that someone is struggling, including: a decline in work performance a...